Encyclopedia of Signaling Molecules

2018 Edition
| Editors: Sangdun Choi

TRPV6

  • Ulrich Wissenbach
Reference work entry
DOI: https://doi.org/10.1007/978-3-319-67199-4_101911

Synonyms

Historical Background

According to the nomenclature of transient receptor (TRP) channels TRPV6 represents the last member of the vanilloid-like TRP (TRPV) subfamily which were named after the first member TRPV1. TRPV1 can be activated by vanilloid-like compounds (Caterina et al. 1999; Montell et al. 2002). TRPV6 was first isolated from rat small intestine using a functional cloning approach (Peng et al. 1999). The human orthologue which shows only 90% identical amino acids to the rat sequence was cloned from a human placenta cDNA library (Wissenbach et al. 2001), and the mouse sequence was cloned by Hirnet and coworkers (Hirnet et al. 2003).

Properties of the TRPV6 Channel

The functional TRPV6 channel consists of four identical subunits, the four TRPV6 proteins, which form...
This is a preview of subscription content, log in to check access.

References

  1. Akey JM, Swanson WJ, Madeoy J, Eberle M, Shriver MD. TRPV6 exhibits unusual patterns of polymorphism and divergence in worldwide populations. Hum Mol Genet. 2006;15:2106–13.PubMedPubMedCentralCrossRefGoogle Scholar
  2. Bianco SD, Peng JB, Takanaga H, Suzuki Y, Crescenzi A, Kos CH, Zhuang L, Freeman MR, Gouveia CH, Wu J, Luo H, Mauro T, Brown EM, Hediger MA. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res. 2007;22:274–85.PubMedPubMedCentralCrossRefGoogle Scholar
  3. Bolanz KA, Hediger MA, Landowski CP. The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther. 2008;7:271–9.PubMedPubMedCentralCrossRefGoogle Scholar
  4. Bolanz KA, Kovacs GG, Landowski CP, Hediger MA. Tamoxifen inhibits TRPV6 activity via estrogen receptor-independent pathways in TRPV6-expressing MCF-7 breast cancer cells. Mol Cancer Res. 2009;7:2000–10.PubMedPubMedCentralCrossRefGoogle Scholar
  5. Bowen CV, DeBay D, Ewart HS, Gallant P, Gormley S, Ilenchuk TT, Iqbal U, Lutes T, Martina M, Mealing G, Merkley N, Sperker S, Moreno MJ, Rice C, Syvitski RT, Stewart JM. In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin. PloS one. 2013;8:e58866.PubMedPubMedCentralCrossRefGoogle Scholar
  6. Caramelli D, Lalueza-Fox C, Vernesi C, Lari M, Casoli A, Mallegni F, Chiarelli B, Dupanloup I, Bertranpetit J, Barbujani G, Bertorelle G. Evidence for a genetic discontinuity between Neandertals and 24,000-year-old anatomically modern Europeans. Proc Natl Acad Sci USA. 2003;100:6593–7.PubMedPubMedCentralCrossRefGoogle Scholar
  7. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature. 1999;398:436–41.CrossRefGoogle Scholar
  8. Chang Q, Hoefs S, van der Kemp AW, Topala CN, Bindels RJ, Hoenderop JG. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science. 2005;310:490–3.PubMedPubMedCentralCrossRefGoogle Scholar
  9. Chen F, Ni B, Yang YO, Ye T, Chen A. Knockout of TRPV6 causes osteopenia in mice by increasing osteoclastic differentiation and activity. Cell Physiol Biochem. 2014;33:796–809.PubMedPubMedCentralCrossRefGoogle Scholar
  10. Erler I, Hirnet D, Wissenbach U, Flockerzi V, Niemeyer BA. Ca2+−selective transient receptor potential V channel architecture and function require a specific ankyrin repeat. J Biol Chem. 2004;279:34456–63.PubMedPubMedCentralCrossRefGoogle Scholar
  11. Fecher-Trost C, Wissenbach U, Beck A, Schalkowsky P, Stoerger C, Doerr J, Dembek A, Simon-Thomas M, Weber A, Wollenberg P, Ruppert T, Middendorff R, Maurer HH, Flockerzi V. The in vivo TRPV6 protein starts at a non-AUG triplet, decoded as methionine, upstream of canonical initiation at AUG. J Biol Chem. 2013;288:16629–44.PubMedPubMedCentralCrossRefGoogle Scholar
  12. Fixemer T, Wissenbach U, Flockerzi V, Bonkhoff H. Expression of the Ca2+−selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression. Oncogene. 2003;22:7858–61.PubMedPubMedCentralCrossRefGoogle Scholar
  13. Haverstick DM, Heady TN, Macdonald TL, Gray LS. Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Res. 2000;60:1002–8.PubMedPubMedCentralGoogle Scholar
  14. Hirnet D, Olausson J, Fecher-Trost C, Bodding M, Nastainczyk W, Wissenbach U, Flockerzi V, Freichel M. The TRPV6 gene, cDNA and protein. Cell Calcium. 2003;33:509–18.PubMedPubMedCentralCrossRefGoogle Scholar
  15. Hoenderop JG, van der Kemp AW, Hartog A, van de Graaf SF, van Os CH, Willems PH, Bindels RJ. Molecular identification of the apical Ca2+ channel in 1, 25-dihydroxyvitamin D3-responsive epithelia. J Biol Chem. 1999;274:8375–8.PubMedPubMedCentralCrossRefGoogle Scholar
  16. Hoenderop JG, Vennekens R, Muller D, Prenen J, Droogmans G, Bindels RJ, Nilius B. Function and expression of the epithelial Ca(2+) channel family: comparison of mammalian ECaC1 and 2. J Physiol. 2001;537:747–61.PubMedPubMedCentralCrossRefGoogle Scholar
  17. Hoenderop JG, Voets T, Hoefs S, Weidema F, Prenen J, Nilius B, Bindels RJ. Homo- and heterotetrameric architecture of the epithelial Ca2+ channels TRPV5 and TRPV6. EMBO J. 2003;22:776–85.PubMedPubMedCentralCrossRefGoogle Scholar
  18. Hofmann L, Wang H, Beck A, Wissenbach U, Flockerzi V. A conserved gating element in TRPV6 channels. Cell Calcium. 2016.  https://doi.org/10.1074/jbc.M113.478305.CrossRefPubMedPubMedCentralGoogle Scholar
  19. Hughes DA, Tang K, Strotmann R, Schoneberg T, Prenen J, Nilius B, Stoneking M. Parallel selection on TRPV6 in human populations. PloS one. 2008;3:e1686.PubMedPubMedCentralCrossRefGoogle Scholar
  20. Kessler T, Wissenbach U, Grobholz R, Flockerzi V. TRPV6 alleles do not influence prostate cancer progression. BMC Cancer. 2009;9:380.PubMedPubMedCentralCrossRefGoogle Scholar
  21. Kovacs G, Montalbetti N, Simonin A, Danko T, Balazs B, Zsembery A, Hediger MA. Inhibition of the human epithelial calcium channel TRPV6 by 2-aminoethoxydiphenyl borate (2-APB). Cell Calcium. 2012;52:468–80.PubMedPubMedCentralCrossRefGoogle Scholar
  22. Landowski CP, Bolanz KA, Suzuki Y, Hediger MA. Chemical inhibitors of the calcium entry channel TRPV6. Pharm Res. 2011;28:322–30.PubMedPubMedCentralCrossRefGoogle Scholar
  23. Luo H, Yu G, Tremblay J, Wu J. EphB6-null mutation results in compromised T cell function. J Clin Invest. 2004;114:1762–73.PubMedPubMedCentralCrossRefGoogle Scholar
  24. McNicholas S, Potterton E, Wilson KS, Noble MEM. Presenting your structures: the CCP4mg molecular-graphics software. Acta Cryst. 2011;D67:386–94.Google Scholar
  25. Merchant SS, Prochnik SE, Vallon O, Harris EH, Karpowicz SJ, Witman GB, Terry A, Salamov A, Fritz-Laylin LK, Marechal-Drouard L, Marshall WF, Qu LH, Nelson DR, Sanderfoot AA, Spalding MH, Kapitonov VV, Ren Q, Ferris P, Lindquist E, Shapiro H, Lucas SM, Grimwood J, Schmutz J, Cardol P, Cerutti H, Chanfreau G, Chen CL, Cognat V, Croft MT, Dent R, Dutcher S, Fernandez E, Fukuzawa H, Gonzalez-Ballester D, Gonzalez-Halphen D, Hallmann A, Hanikenne M, Hippler M, Inwood W, Jabbari K, Kalanon M, Kuras R, Lefebvre PA, Lemaire SD, Lobanov AV, Lohr M, Manuell A, Meier I, Mets L, Mittag M, Mittelmeier T, Moroney JV, Moseley J, Napoli C, Nedelcu AM, Niyogi K, Novoselov SV, Paulsen IT, Pazour G, Purton S, Ral JP, Riano-Pachon DM, Riekhof W, Rymarquis L, Schroda M, Stern D, Umen J, Willows R, Wilson N, Zimmer SL, Allmer J, Balk J, Bisova K, Chen CJ, Elias M, Gendler K, Hauser C, Lamb MR, Ledford H, Long JC, Minagawa J, Page MD, Pan J, Pootakham W, Roje S, Rose A, Stahlberg E, Terauchi AM, Yang P, Ball S, Bowler C, Dieckmann CL, Gladyshev VN, Green P, Jorgensen R, Mayfield S, Mueller-Roeber B, Rajamani S, Sayre RT, Brokstein P, et al. The Chlamydomonas genome reveals the evolution of key animal and plant functions. Science. 2007;318:245–50.PubMedPubMedCentralCrossRefGoogle Scholar
  26. Montell C, Birnbaumer L, Flockerzi V, Bindels RJ, Bruford EA, Caterina MJ, Clapham DE, Harteneck C, Heller S, Julius D, Kojima I, Mori Y, Penner R, Prawitt D, Scharenberg AM, Schultz G, Shimizu N, Zhu MX. A unified nomenclature for the superfamily of TRP cation channels. Mol Cell. 2002;9:229–31.PubMedPubMedCentralCrossRefGoogle Scholar
  27. Muller D, Hoenderop JG, Meij IC, van den Heuvel LP, Knoers NV, den Hollander AI, Eggert P, Garcia-Nieto V, Claverie-Martin F, Bindels RJ. Molecular cloning, tissue distribution, and chromosomal mapping of the human epithelial Ca2+ channel (ECAC1). Genomics. 2000;67:48–53.PubMedPubMedCentralCrossRefGoogle Scholar
  28. Niemeyer BA, Bergs C, Wissenbach U, Flockerzi V, Trost C. Competitive regulation of CaT-like-mediated Ca2+ entry by protein kinase C and calmodulin. Proc Natl Acad Sci USA. 2001;98:3600–5.PubMedPubMedCentralCrossRefGoogle Scholar
  29. Nijenhuis T, Hoenderop JG, van der Kemp AW, Bindels RJ. Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidney. J Am Soc Nephrol. 2003;14:2731–40.PubMedPubMedCentralCrossRefGoogle Scholar
  30. Nilius B, Prenen J, Vennekens R, Hoenderop JG, Bindels RJ, Droogmans G. Pharmacological modulation of monovalent cation currents through the epithelial Ca2+ channel ECaC1. Br J Pharmacol. 2001a;134:453–62.PubMedPubMedCentralCrossRefGoogle Scholar
  31. Nilius B, Vennekens R, Prenen J, Hoenderop JG, Droogmans G, Bindels RJ. The single pore residue Asp542 determines Ca2+ permeation and Mg2+ block of the epithelial Ca2+ channel. J Biol Chem. 2001b;276:1020–5.PubMedPubMedCentralCrossRefGoogle Scholar
  32. Peng JB. TRPV5 and TRPV6 in transcellular Ca(2+) transport: regulation, gene duplication, and polymorphisms in African populations. Adv Exp Med Biol. 2011;704:239–75.PubMedPubMedCentralCrossRefGoogle Scholar
  33. Peng JB, Chen XZ, Berger UV, Vassilev PM, Tsukaguchi H, Brown EM, Hediger MA. Molecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorption. J Biol Chem. 1999;274:22739–46.PubMedPubMedCentralCrossRefGoogle Scholar
  34. Peng JB, Chen XZ, Berger UV, Vassilev PM, Brown EM, Hediger MA. A rat kidney-specific calcium transporter in the distal nephron. J Biol Chem. 2000;275:28186–94.PubMedPubMedCentralGoogle Scholar
  35. Pennisi E. Human evolution. Genomes throw kinks in timing of chimp-human split. Science. 2006;312:985–6.PubMedPubMedCentralCrossRefGoogle Scholar
  36. Saotome K, Singh AK, Yelshanskaya MV, Sobolevsky AI. Crystal structure of the epithelial calcium channel TRPV6. Nature. 2016;534:506–11.PubMedPubMedCentralCrossRefGoogle Scholar
  37. Schwarz EC, Wissenbach U, Niemeyer BA, Strauss B, Philipp SE, Flockerzi V, Hoth M. TRPV6 potentiates calcium-dependent cell proliferation. Cell Calcium. 2006;39:163–73.PubMedPubMedCentralCrossRefGoogle Scholar
  38. Stringer CB, Andrews P. Genetic and fossil evidence for the origin of modern humans. Science. 1988;239:1263–8.PubMedPubMedCentralCrossRefGoogle Scholar
  39. Vassilev PM, Peng JB, Hediger MA, Brown EM. Single-channel activities of the human epithelial Ca2+ transport proteins CaT1 and CaT2. J Membr Biol. 2001;184:113–20.PubMedPubMedCentralCrossRefGoogle Scholar
  40. Vennekens R, Hoenderop JG, Prenen J, Stuiver M, Willems PH, Droogmans G, Nilius B, Bindels RJ. Permeation and gating properties of the novel epithelial Ca(2+) channel. J Biol Chem. 2000;275:3963–9.PubMedPubMedCentralCrossRefGoogle Scholar
  41. Voets T, Janssens A, Prenen J, Droogmans G, Nilius B. Mg2+-dependent gating and strong inward rectification of the cation channel TRPV6. J Gen Physiol. 2003;121:245–60.PubMedPubMedCentralCrossRefGoogle Scholar
  42. Weissgerber P, Kriebs U, Tsvilovskyy V, Olausson J, Kretz O, Stoerger C, Vennekens R, Wissenbach U, Middendorff R, Flockerzi V, Freichel M. Male fertility depends on Ca(2)+ absorption by TRPV6 in epididymal epithelia. Sci Signal. 2011;4:ra27.PubMedPubMedCentralCrossRefGoogle Scholar
  43. Weissgerber P, Kriebs U, Tsvilovskyy V, Olausson J, Kretz O, Stoerger C, Mannebach S, Wissenbach U, Vennekens R, Middendorff R, Flockerzi V, Freichel M. Excision of Trpv6 gene leads to severe defects in epididymal Ca2+ absorption and male fertility much like single D541A pore mutation. J Biol Chem. 2012;287:17930–41.PubMedPubMedCentralCrossRefGoogle Scholar
  44. Wissenbach U, Niemeyer BA. TRPV6. Handb Exp Pharmacol. 2007;179:221–34.CrossRefGoogle Scholar
  45. Wissenbach U, Niemeyer BA, Fixemer T, Schneidewind A, Trost C, Cavalie A, Reus K, Meese E, Bonkhoff H, Flockerzi V. Expression of CaT-like, a novel calcium-selective channel, correlates with the malignancy of prostate cancer. J Biol Chem. 2001;276:19461–8.PubMedPubMedCentralCrossRefGoogle Scholar
  46. Wissenbach U, Niemeyer B, Himmerkus N, Fixemer T, Bonkhoff H, Flockerzi V. TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression. Biochem Biophys Res Commun. 2004;322:1359–63.PubMedPubMedCentralCrossRefGoogle Scholar
  47. Yue L, Peng JB, Hediger MA, Clapham DE. CaT1 manifests the pore properties of the calcium-release-activated calcium channel. Nature. 2001;410:705–9.PubMedPubMedCentralCrossRefGoogle Scholar
  48. Zhuang L, Peng JB, Tou L, Takanaga H, Adam RM, Hediger MA, Freeman MR. Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies. Lab Invest. 2002;82:1755–64.PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Institute of Experimental and Clinical Pharmacology and ToxicologySaarland UniversityHamburgGermany